Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"Pharmacy Administration, Policy and Regulation"”.
-
Reducing Medication Errors by Systematically Monitoring High-Risk Medications
… years old with severe abnormal lung findings and often with multiple comorbidities. The clinic is staffed by pulmonary fellows in three-year rotations, providing two four hour clinics each week. They see 850 patients in a year, some of whom are seen every two, three or six months. The fellows …
-
An Economic and Regulatory Analysis of Gene Therapy Products Authorized by the US Food and Drug Administration and the European Medicines Agency
… emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies.</p> <p>Objective: This study assessed the authorization process of gene therapy products by the Food and Drug Administration (FDA) and …
-
The Effects Orthostatic Hypotension has on Falls: A study done in San Francisco with the Patient Population of the Veterans Affairs Hospital
… The patients were not identified as a fall risk and over half of them had fallen multiple times. After performing a nursing survey online, a SWOT analysis, and a Root Cause Analysis using a fishbone diagram, The problem was identified as a gap in knowledge for the assessment of OH and poor …
-
Pharmacovigilance in Post-Marketing: Risk Assessment and Reporting Standards
… poor prognosis. Over time the arteries stiffen and tighten subsequently leaving the heart to pump harder to try and provide enough blood to the body. The extra stress of the increased pumping leads to weakening and enlargement of the heart. The endothelin targeted therapy, Letairis …
-
An Analysis of Trends of Generic Drugs and Biologic Prices in the U.S.
… problem for the US healthcare system. Generic and biosimilar market competition reduces drug and biologic prices, results in substantial savings, and improves patient access and outcomes. As the costs of healthcare and prescription drugs continue to rise, the discussion about drug prices has …
-
Orphan Drugs: Designations, Approvals, and Prices in the US
… the characteristics of orphan drug designations and approvals and the factors associated with the time lag between orphan designation and approval in the US from 1983 to 2021. It also evaluated the treatment cost of orphan and non-orphan drugs and factors explaining the treatment cost of new …
-
An Economic and Regulatory Analysis of Breast Cancer Drugs Approved by the US Food and Drug Administration
… cancer is the most common cancer among women and the leading cause of cancer death among women worldwide. The pharmacological options for breast cancer include chemotherapy, hormone therapy, targeted therapy, and immunotherapy, which are used for the prevention or treatment of breast cancer. …
-
Community Pharmacists and Substance Use Disorders: Attitudes, Knowledge and Practices
… are well-positioned to prevent, screen, and provide appropriate treatment for SUD. Stigma towards these patients and SUD results in reduced quality of care as well as poor treatment outcomes. It is imperative that pharmacists have the appropriate knowledge of and attitude towards …
-
Approvals, Utilization, and Cost of Biologics for the Treatment of Rheumatoid Arthritis
… has been revolutionized by the development and approval of biologic disease-modifying antirheumatic drugs (bDMARDs). However, the approval status, utilization, and high cost of bDMARDs pose challenges in RA management.</p> <p><strong>Objectives:</strong> This dissertation evaluated the …
-
Approvals and Prices of Systemic Antibiotics in Saudi Arabia and the United States
… diffusion of antibiotics, their availability and prices vary by country. This study assessed differences in the availability and prices of systemic antibiotics marketed in the United States (US) and Saudi Arabia and evaluated the factors associated with the differences in prices of systemic …
-
Evaluating Consumer Preferences for Medicare Part D Using Conjoint Analysis
… must be sensitive to differences in price and the quality of benefits amongst different plans. This study sought to evaluate the relative importance seniors place on different attributes of Medicare Part D drug plans using a marketing technique called conjoint analysis.</p> <p>An Adaptive …
-
Patient Satisfaction with Substance Use Disorder Rehabilitation Services
… healthcare quality across an array of treatments and services. It is deemed vital especially in the field of substance use disorder (SUD) research due to an increased emphasis on understanding patients’ perceptions regarding their treatment and the attributes that drive their progress towards …
-
Authorizations, Prices, and Labeling Differences of Therapeutic Biologics Marketed in the United States and Saudi Arabia
<p>BACKGROUND: Since 1982, Saudi Arabia (SA) and the United States (US) have seen an increase in therapeutic biologics authorization. However, each country has regulatory regulations governing the approval of these cutting-edge drugs. The high cost of biologics financially burdens healthcare …
-
An Exploration of Ambulatory Visits and Medications Prescribed for Patients Diagnosed with Lupus Erythematosus in the United States
<p>This dissertation sought to understand the management and treatment of patients diagnosed with lupus erythematosus. To accomplish the objectives of this research, three studies were conducted. First, a systematic literature review was done to assess the current landscape of available clinical …
-
Cost-Effectiveness Analysis of Tisagenlecleucel, Blinatumomab, and Clofarabine for Treatment of B-cell Precursor Acute Lymphoblastic Leukemia
… leukemia (ALL) is a common type of adolescent and young adult leukemia in the United States (U.S.). Patients who are refractory or relapsed after receiving two or more lines of systemic therapy have the option of taking tisagenlecleucel. Due to the high cost of this treatment, a …
-
The Association Between Medication Adherence in Mental Illness and Substance Use Disorder Relapse in Patients with Dual Diagnosis
… the study were to (1) identify personal, social, and clinical history for patients with substance use disorder (SUD) and mental illness, (2) measure agreeance between patient self-report versus facility record history for mental illness, substance abuse, and psychotropic medication, (3) …
-
Awareness And Utilization Of The Ohio Automated Rx Reporting System By Physician Assistants
… drug abuse/misuse. There is no clear standardization of who utilizes the PDMP and how. Little is still known about the ways PDMP results are incorporated into clinical decision making, what barriers exist, and how providers may or may not alter their prescribing plans based on the …
-
Burden of Illness and Pharmacoeconomic Evaluation of Lumacaftor/Ivacaftor in Cystic Fibrosis
… Medical Expenditure Panel Survey (MEPS) data, and (2) to conduct a pharmacoeconomic evaluation of lumacaftor/ivacaftor in the treatment of CF. <strong></strong></p> <p><strong>Methods:</strong> The study was conducted in two parts. Part 1 involved a retrospective analysis using individuals in …
-
Perceptions of Metabolic Syndrome Management Utilization in relation with Patient Characteristics and Health-related Quality of Life
… in managing MetS include untreated risk factors and ineffective management, resulting in poor health-related quality of life (HRQoL). A significant factor contributing to these challenges is the underutilization of management services, possibly due to patients' perceptions of disease management …
-
Why Pharmacists Choose to Seek or Not Seek Board Certification in Pharmacy Practice: A Comparison of Motivation and Motivating Factors
… to recognize specialty areas, define skill standards for those specialty areas, and evaluate the knowledge and skills of individual Pharmacy specialists. The perceived or real benefits to the pharmacist of pursuing board certification are unknown. These benefits can be evaluated by separating …